{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "USD", "marketState": "PRE", "messageBoardId": "finmb_115979478", "regularMarketChangePercent": 39.13043, "regularMarketPrice": 0.0032, "exchange": "PNK", "shortName": "THERAPEUTIC SOLUTIONS INTL INC", "longName": "Therapeutic Solutions International, Inc.", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "firstTradeDateMilliseconds": 1214314200000, "priceHint": 4, "regularMarketChange": 0.00089999987, "regularMarketTime": 1684180755, "regularMarketDayHigh": 0.0032, "regularMarketDayRange": "0.0022 - 0.0032", "regularMarketDayLow": 0.0022, "regularMarketVolume": 28743912, "regularMarketPreviousClose": 0.0023, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "Other OTC", "financialCurrency": "USD", "regularMarketOpen": 0.0024, "averageDailyVolume3Month": 13735490, "averageDailyVolume10Day": 21098672, "fiftyTwoWeekLowChange": 0.00131, "fiftyTwoWeekLowChangePercent": 0.6931217, "fiftyTwoWeekRange": "0.00189 - 0.025", "fiftyTwoWeekHighChange": -0.0218, "fiftyTwoWeekHighChangePercent": -0.872, "fiftyTwoWeekLow": 0.00189, "fiftyTwoWeekHigh": 0.025, "earningsTimestamp": 1597867200, "earningsTimestampStart": 1605819600, "earningsTimestampEnd": 1605906000, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.0, "sharesOutstanding": 2734249984, "bookValue": 0.001, "fiftyDayAverage": 0.0029334, "fiftyDayAverageChange": 0.00026659993, "fiftyDayAverageChangePercent": 0.090884276, "twoHundredDayAverage": 0.00809995, "twoHundredDayAverageChange": -0.0048999498, "twoHundredDayAverageChangePercent": -0.6049358, "marketCap": 8749600, "priceToBook": 3.1999998, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "tradeable": false, "cryptoTradeable": false, "displayName": "Therapeutic", "symbol": "TSOI"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "701 Wild Rose Lane", "city": "Elk City", "state": "ID", "zip": "83525", "country": "United States", "phone": "760 295 7208", "website": "https://www.therapeuticsolutionsint.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, traumatic brain injury, and lung pathologies, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production. The company also produces nutraceuticals, including ProJuvenol, a synergistic blend of complex anti-aging ingredients in capsules; NanoStilbene, a nanoemulsion of nanoparticle pterostilbene; DermalStilbene, a topical form of pterostilbene delivered through spray application onto skin; IsoStilbene, an injectable formulation of pterostilbene; NeuroStilbene, an intranasal form of pterostilbene; NanoPSA, a blend of NanoStilbene and broccoli sprout extracts; and NLRP3 Trifecta, a two-product combo that consists of one bottle of NanoPSA and one bottle of GTE-50 green tea extract. In addition, it develops therapeutics in chronic traumatic encephalopathy, and traumatic brain injury and lung pathology. Therapeutic Solutions International, Inc. was founded in 2007 and is headquartered in Elk City, Idaho.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Mr. Timothy George Dixon", "age": 64, "title": "Chairman, CEO, Pres & CFO", "yearBorn": 1958, "fiscalYear": 2022, "totalPay": {"raw": 240000, "fmt": "240k", "longFmt": "240,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Feng  Lin M.D., Ph.D.", "age": 51, "title": "Chief Scientific Officer", "yearBorn": 1971, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. James Drew Veltmeyer M.D.", "age": 56, "title": "Chief Medical Officer, Vice Chairman of CTE Advisory Board & Member of Scientific Advisory Board", "yearBorn": 1966, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Famela  Ramos", "age": 45, "title": "VP of Bus. Devel.", "yearBorn": 1977, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Serena  Robella", "title": "Director of Sales", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}